The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
Premium- Israel-based Pluristem (NASDAQ:PSTI) announced that treatment with its Placental eXpanded (PLX) cells saved the life of a cancer patient with pancytopenia, a dangerous reduction in … Continue Reading
Read now- The FDA gave approval on Friday for ten drugmakers to begin marketing generic versions of Singulair, Merck’s (NYSE:MRK) $5B asthma treatment. Investors and analysts have … Continue Reading
Read now- Acorda Therapeutics (NASDAQ:ACOR) is expected to announce trial results for its lead drug Ampyra in a 5mg dose (not an approved strength), which was part … Continue Reading
Read now- OXiGENE, Inc. (NASDAQ:OXGN) reported interim results from a Phase II ovarian cancer study evaluating a combination of Zybrestat and bevacizumab. The two drugs passed a … Continue Reading
Read now- Alexion Pharmaceuticals (NASDAQ:ALXN) continued to show top-line growth in its second quarter report issued last week. The company beat analyst expectations for the quarter and … Continue Reading
Read nowShort Ideas - ResMed (NYSE:RMD) reported revenues of $371.9 million and EPS of $0.53 for its fiscal fourth quarter (ended June), above Wall Street consensus estimates of $368 … Continue Reading
Read nowLong Ideas - After its Q2 earnings report was released last night, Obagi Medical Products (NASDAQ:OMPI) took a dive this morning, down 22.5% just after the bell. The … Continue Reading
Read now
